Filspari Treats Kidney Disease
Share
Filspari (sparsentan) is an FDA-approved medication for treating kidney disease and managing protein in urine. This treatment option helps patients dealing with kidney-related health challenges.
Related products include:
- Zokinvy (lonafarnib) - FDA-approved treatment
- Vascepa - Cardiovascular health medication
- Amarin Products - Portfolio of cardiovascular treatments
24:01 - 28:44
Full video: 01:42:17MS
Martin Shkreli
Former hedge fund manager and pharmaceutical executive. Founded Retrophin and Turing Pharmaceuticals, gaining notoriety for increasing the price of Daraprim.
Convicted of securities fraud in 2017, sentenced to seven years in federal prison. Banned from the pharmaceutical industry and ordered to return $64.6 million in profits.